Health ❯ Medicine

Neurology

Alzheimer's Disease Neurodegenerative Diseases Parkinson's Disease Neurological Disorders Dementia Epilepsy Brain Injuries Neurological Conditions Cognitive Health Brain Disorders Brain Diseases Cognitive Disorders Migraine Movement Disorders Cognitive Decline Brain Imaging Neurodegeneration Neurologist Multiple Sclerosis Brain Health Spinal Cord Injury Cognitive Function Cognitive Assessment Neurological Diseases Brain Inflammation Memory Formation Brain Cells Aphasia Brain Surgery Neurologists Brain Aneurysm Traumatic Brain Injury Brain Function Neurodevelopmental Disorders COVID-19 Brain Implants Stroke Visual Disorders Neurodegenerative Disorders Pain Management Neurological Exam Brain Impact of Non-Neurological Diseases Strokes Autism Spectrum Disorder Neuralink Technology Blood-Brain Barrier Facial Recognition Disorders Rare Diseases Sleep Disorders Gaza Genomic Instability Psychological Disorders Intellectual Disorders Alzheimer's disease Nerve Regeneration Parasites Brain Tumor Brain Death Brain Tumors Vascular Dementia Genetic Disorders Neuropathies Nerve Injury Seizures Neuroinflammation Neuroimmunology Space Medicine Alcohol Effects Spinal Cord Injuries Brain Functions Pediatrics Brain Stimulation Brain Signals Neurological Testing Neurologist Visits White House Medical Clinic Presidential Annual Checkups White House Operations Neurology Clinics Cognitive abilities Parkinson's Cognitive Exam Neural Dynamics Psychedelic Drugs Inherited Conditions Neuromodulation Neurostimulation Brain Injury Cerebrospinal Fluid Memory Psychiatric disorders Cognitive Development Brain development Brain networks Brain features Long COVID Language Disorders Sleep Medicine Brain Development

Preliminary Study Links GLP-1 Drugs to Fewer ER Visits in Chronic Migraine

The retrospective analysis set for presentation at April’s AAN meeting reports associations, not proof of benefit.

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Alzheimer’s Study Finds Memory “Replay” Persists but Loses Structure

Glial Cells Deliver Mitochondria to Neurons, Easing Pain in Mice

Tau Neutralizes HSV-1 in Human Neuron Cultures, Pointing to Antiviral Roots of Alzheimer’s Features

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Praxis Relutrigine Study Halted Early for Efficacy as FDA Review Meeting Set

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

New Review Positions Camelid Nanobodies as a Promising Path for Brain Therapies

Study Finds PU.1-Low, CD28-Positive Microglia Curb Alzheimer’s Damage

Engineered Nanoparticles Restore Blood–Brain Barrier and Clear Amyloid in Alzheimer’s Mice

Nanoparticles Restore Brain Barrier, Reverse Alzheimer’s Signs in Mice

Inhaled CBD Dampens Brain Inflammation in Alzheimer’s Mouse Model

Lancet Series Calls for Health-System Overhaul to Deliver New Alzheimer’s Blood Tests and Antibody Drugs

Neuron-Microglia Signal Near Plaques Emerges as a Potential Alzheimer’s Target

Alzheimer’s Study Ties Familial SORL1 Variant to Fewer, Weaker Brain Exosomes

Rapport Seizure Drug Posts Strong Phase 2 Signal as Company Plans Phase 3

Chronic Neuron Overactivity in Mice Triggers Parkinson’s-Like Dopamine Cell Loss

Tumor-Induced Nerve Injury Identified as Driver of Anti–PD-1 Resistance

Early Smell Loss in Alzheimer’s Driven by Microglial Axon Removal